Vivek Vaish
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
- Pharmacology 19
- Inflammatory mediators and NSAID effects 19
- Co-authors
- Sankar Nath Sanyal (24 shared papers)Honit Piplani (10 shared papers)Lalita Tanwar (4 shared papers)Maria Marjorette O. Peña (1 shared paper)Bimla Nehru (3 shared papers)Minsub Shim (3 shared papers)Kim Vaiphei (2 shared papers)Manpreet Kaur Saini (1 shared paper)
- Journals
- Molecular and Cellular Biochemistry (5 papers)European Journal of Cancer Prevention (3 papers)Biomedicine & Pharmacotherapy (3 papers)Cell Biochemistry and Biophysics (2 papers)Tumor Biology (2 papers)
- Partner nations
- IndiaUnited States
In The Last Decade
Vivek Vaish
31 papers receiving 659 citations
Peers
Comparison fields: 5 of 84
- Pharmacology 151
- Molecular Medicine 42
- Cancer Research 78
- Immunology 108
- Psychiatry and Mental health 69
Countries citing papers authored by Vivek Vaish
This map shows the geographic impact of Vivek Vaish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Vaish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Vaish more than expected).
Fields of papers citing papers by Vivek Vaish
This network shows the impact of papers produced by Vivek Vaish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Vaish. The network helps show where Vivek Vaish may publish in the future.
Co-authors
The 18 scholars most cited alongside Vivek Vaish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 87 | |
| 2 | 2015 | 68 | |
| 3 | 2013 | 38 | |
| 4 | 2012 | 37 | |
| 5 | 2011 | 35 | |
| 6 | 2016 | 35 | |
| 7 | 2010 | 32 | |
| 8 | 2012 | 28 | |
| 9 | 2017 | 27 | |
| 10 | 2015 | 24 | |
| 11 | 2012 | 23 | |
| 12 | 2013 | 20 | |
| 13 | Chemoprevention of 1,2-dimethylhydrazine-induced colon carcinogenesis by a non-steroidal anti-inflammatory drug, etoricoxib, in rats: inhibition of nuclear factor kappaB. | 2009 | 20 |
| 14 | 2013 | 18 | |
| 15 | 2010 | 18 | |
| 16 | 2012 | 18 | |
| 17 | 2012 | 17 | |
| 18 | 2012 | 16 | |
| 19 | 2012 | 15 | |
| 20 | 2012 | 15 |
About Vivek Vaish
Vivek Vaish is a scholar working on Pharmacology, Molecular Biology, Genetics, Psychiatry and Mental health and Oncology, having authored 31 papers that have together received 668 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (19 papers), Estrogen and related hormone effects (11 papers), Cancer, Stress, Anesthesia, and Immune Response (9 papers), Drug Transport and Resistance Mechanisms (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Cancer-related Molecular Pathways (2 papers), Synthesis and biological activity (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Pharmacology (151 citations), Molecular Medicine (42 citations), Cancer Research (78 citations), Immunology (108 citations) and Psychiatry and Mental health (69 citations). Vivek Vaish has collaborated with scholars based in India and United States. Frequent co-authors include Sankar Nath Sanyal, Honit Piplani, Lalita Tanwar, Maria Marjorette O. Peña, Bimla Nehru, Minsub Shim, Kim Vaiphei, Manpreet Kaur Saini, Mingxiao Feng and Ioulia Chatzistamou. Their work appears in journals such as Molecular and Cellular Biochemistry, European Journal of Cancer Prevention, Biomedicine & Pharmacotherapy, Cell Biochemistry and Biophysics and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.